-
Mental Health Week 2024
https://braincanada.ca/about/news-updates/mental-health-week-2024If you are interested in attending a Brain Canada event on youth mental health, please let us know by filling out the form below. We will add you to our list and be sure to send you relevant event invitations. Thank you!
-
Message to our community of supporters
https://braincanada.ca/about/news-updates/message-to-our-community-of-supportersBrain Canada is alert to the impact COVID-19 is having on the research community. The current pandemic reinforces the need for strong, rigorous, fact-based information, and support towards the scientific community. Brain Canada has a business continuity plan in place and we are working remotely to...
-
Methylphenidate primed iTBS for apathy in neurocognitive disorders
https://braincanada.ca/funded-grants/methylphenidate-primed-itbs-for-apathy-in-neurocognitive-disordersApathy (reduced goal-directed behaviour) is common in persons with dementia and is associated with lower quality of life, increased dependence and faster decline. Project Overview Apathy (reduced goal-directed behaviour) is common in persons with dementia and is associated with lower quality of...
-
Microbiota-Microglia Interactions in Pediatric Inflammatory Bowel Disease
https://braincanada.ca/funded-grants/microbiota-microglia-interactions-in-pediatric-inflammatory-bowel-diseaseDespite the recent advances in our understanding between the connection between the microbes living in the gut and our mental health, there remains a wide knowledge gap in understanding how the brain is negatively impacted in disorders with inflammation of the gut. Project Overview Despite the...
-
Microfluidic Screening Technology for the Discovery of Function-Modifying Antibodies Against Membrane Protein Targets
https://braincanada.ca/funded-grants/microfluidic-screening-technology-for-the-discovery-of-function-modifying-antibodies-against-membrane-protein-targetsAntibody (Ab)-based therapeutics are the fastest growing class of drugs, with approximately 60 approved molecules that represent a market of over $80B. Project Overview Antibody (Ab)-based therapeutics are the fastest growing class of drugs, with approximately 60 approved molecules that represent a...
-
Microglia and Vapourized Cannabis
https://braincanada.ca/funded-grants/microglia-and-vapourized-cannabisMicroglia, the brain’s resident immune cells, are vital for healthy brain function. Project Overview Microglia, the brain’s resident immune cells, are vital for healthy brain function. This is partially accomplished through their interactions with the primary brain cells, neurons, and those cells’...
-
MicroRNA biomarkers: Using Tears to Assess Alzheimer’s Disease
https://braincanada.ca/funded-grants/microrna-biomarkers-using-tears-to-assess-alzheimer-s-diseaseAlzheimer’s disease (AD) is the most common form of dementia and 7th leading cause of death in North-America. Project Overview Alzheimer’s disease (AD) is the most common form of dementia and 7th leading cause of death in North-America. It affects memory, thinking and behavior, thus causing major...
-
Mind Over Matter
https://braincanada.ca/funded-grants/mind-over-matterPartners and Donors Women's Brain Health Initiative
-
Mind Over Matter Magazine
https://braincanada.ca/funded-grants/mind-over-matter-magazinePartners and Donors Women's Brain Health Initiative
-
Mind Over Matter Magazine
https://braincanada.ca/funded-grants/mind-over-matter-magazine-15Partners and Donors Women's Brain Health Initiative